Contact Us CEUFast.com/support
CEUFast.com Home Page MyAccount Course Catalog About CEUFast.com Links and other Resources Help & FAQ
Arrow Icon Print this Course Take Test for this Course
 
Stylesheet CEUFast CSS Header 3

Preventing Needlestick Injuries
Author:
Julia Tortorice  Course Expiration: 

 

Preventing Needlestick Injuries | Copyright © 2007 CEUFast.com


Course Contents

   Purpose/Goals
   Objectives
   Introduction
   Employers
   Healthcare workers
   Impact of Needlestick Injury
       HIV
       HBV
       HCV
   Risk of Infection after a Needlestick Injury
       HIV
       HBV
       HCV
   How Needlestick Injuries Occur
   Devices Associated with Needlestick Injuries
   Activities Associated with Needlestick
     Injuries

   OSHA and FDA
       OSHA
       FDA
   OSHA and FDA
       Case 1
       Case 2
       Case 3
       Case 4
       Case 5
   Improved Engineering Controls
       Comprehensive Programs to Prevent
         Needlestick Injuries

       Case Study of a Successful
         Comprehensive Prevention Program
         (NIOSH. 1999)

       Desirable Characteristics of Devices with
         Safety Features

       Examples of Safety Device Designs
       Evidence of Effectiveness
   Recommendations
       Selecting and Evaluating Needle Devices
         with Safety Features

       Recommendations for Employers
       Recommendations for Workers
   Additional Information
   Reference

   Click any section in the index above to browse to the corresponding course section 

 

Purpose/Goals

The purpose of this course is to assist healthcare workers in avoiding needlestick injuries and to provide an update on current CDC recommendations of treatment after a needlestick.

 

Objectives

After completing the course the learner will be able to:

1. identify the way that needlestick injuries can best be reduced,
   
2. recognize the risk of occupational transmission of HIV, HBV and HCV,
   
3. discuss the limited value of pre-exposure vaccination or post-exposure prophylaxis,
   
4. identify devices and activities most commonly associated with needlestick injuries, and
   
5. identify the desirable characteristics of safety devices.

 

Introduction

The CDC estimates that 384,325 percutaneous injuries occur each year in U.S. hospitals. According TO EPINet (Exposure Prevention Information Network) data for 2001. Nurses sustained the largest proportion (44%) of sharps injuries of all healthcare professionals, but laboratory staff, physicians, housekeepers, and other healthcare workers are also injured (Perry, Jagger & Parker, 2003). Some of these injuries expose workers to bloodborne pathogens that can cause infection. The most important of these pathogens are HBV, HCV, and HIV. Infections with each of these pathogens are potentially life threatening—and preventable.

 

Employers

Employers of healthcare workers should implement the use of improved engineering controls to reduce needlestick injuries:

  Eliminate the use of needles where safe and effective alternatives are available.
   
  Implement the use of devices with safety features and evaluate their use to determine which are most effective and acceptable.

Since 1993 the use of safety-engineered sharps devices has increased while the use of conventional sharps devices has decreased. Percutaneous injury rates decreased dramatically (Perry, Jagger & Parker, 2003). Needlestick injuries can best be reduced when the use of improved engineering controls is incorporated into a comprehensive program involving workers. Employers should implement the following program elements (NIOSH, 1999):

  Analyze needlestick and other sharps-related injuries in your workplace to identify hazards and injury trends.
   
  Set priorities and strategies for prevention by examining local and national information about risk factors for needlestick injuries and successful intervention efforts.
   
  Ensure that healthcare workers are properly trained in the safe use and disposal of needles.
   
  Modify work practices that pose a needlestick injury hazard to make them safer.
   
  Promote safety awareness in the work environment.
   
  Establish procedures for and encourage the reporting and timely followup of all needlestick and other sharps-related injuries.
   
  Evaluate the effectiveness of prevention efforts and provide feedback on performance.

 

Healthcare workers

Healthcare workers should take the following steps to protect themselves and their fellow workers from needlestick injuries (NIOSH, 1999):

  Avoid the use of needles where safe and effective alternatives are available.
   
  Help your employer select and evaluate devices with safety features.
   
  Use devices with safety features provided by your employer.
   
  Avoid recapping needles.
   
  Plan for safe handling and disposal before beginning any procedure using needles.
   
  Dispose of used needles promptly in appropriate sharps disposal containers.
   
  Report all needlestick and other sharps-related injuries promptly to ensure that you receive appropriate followup care.
   
  Tell your employer about hazards from needles that you observe in your work environment.
   
  Participate in bloodborne pathogen training and follow recommended infection prevention practices, including hepatitis B vaccination.

Percutaneous needlestick injuries are caused by needles such as hypodermic needles, blood collection needles, intravenous (IV) stylets, and needles used to connect parts of IV delivery systems. These injuries may cause a number of serious and potentially fatal infections with bloodborne pathogens such as hepatitis B virus (HBV), hepatitis C virus (HCV), or human immunodeficiency virus (HIV)—the virus that causes acquired immunodeficiency syndrome (AIDS).

These injuries can be avoided by eliminating the unnecessary use of needles, using devices with safety features, and promoting education and safe work practices for handling needles and related systems. These measures should be part of a comprehensive program to prevent the transmission of bloodborne pathogens.

 

Impact of Needlestick Injury

The emotional impact of a needlestick injury can be severe and long lasting, even when a serious infection is not transmitted. This impact is particularly severe when the injury involves exposure to HIV. In one study of 20 healthcare workers with an HIV exposure, 11 reported acute severe distress, 7 had persistent moderate distress, and 6 quit their jobs as a result of the exposure (NIOSH, 1999). Other stress reactions requiring counseling have also been reported. Not knowing the infection status of the source patient can accentuate the healthcare worker’s stress. In addition to the exposed healthcare worker, colleagues and family members may suffer emotionally.

HIV

Between 1985 and June 1999, cumulative totals of 55 "documented"† cases and 136 possible cases of occupational HIV transmission to U.S. healthcare workers were reported to the Centers for Disease Control and Prevention (NIOSH, 1999). Most involved nurses and laboratory technicians. Percutaneous injury (e.g., needlestick) was associated with 49 (89%) of the documented transmissions. Of these, 44 involved hollow-bore needles, most of which were used for blood collection or insertion of an IV catheter.

HIV infection is a complex disease that can be associated with many symptoms. The virus attacks part of the body’s immune system, eventually leading to severe infections and other complications—a condition known as AIDS. Despite current therapies that delay the progression of HIV disease, most healthcare workers who become infected with HIV are likely to eventually develop AIDS and die.

HBV

In 1995, an estimated 800 healthcare workers became infected with HBV. This figure represented a 95% decline from the 17,000 new infections estimated in 1983. The decline was largely due to the widespread immunization of healthcare workers with the hepatitis B vaccine and the use of universal precautions and other measures required by the Occupational Safety and Health Administration (OSHA) bloodborne pathogens standard (NIOSH, 1999).

About one-third to one-half of persons with acute HBV infection develop symptoms of hepatitis such as jaundice, fever, nausea, and abdominal pain. Most acute infections resolve, but 5% to 10% of patients develop chronic infection with HBV that carries an estimated 20% lifetime risk of dying from cirrhosis and 6% risk of dying from liver cancer (NIOSH. 1999).

HCV

Hepatitis C virus infection is the most common chronic bloodborne infection in the United States, affecting approximately 4 million people. Although the prevalence of HCV infection among healthcare workers is similar to that in the general population (1% to 2%), healthcare workers clearly have an increased occupational risk for HCV infection (NIOSH. 1999). The number of healthcare workers who have acquired HCV occupationally is not known. However, of the total acute HCV infections that have occurred annually (ranging from 100,000 in 1991 to 36,000 in 1996), 2% to 4% have been in healthcare workers exposed to blood in the workplace (NIOSH. 1999).

HCV infection often occurs with no symptoms or only mild symptoms. But unlike HBV, chronic infection develops in 75% to 85% of patients, with active liver disease developing in 70%. Of the patients with active liver disease, 10% to 20% develop cirrhosis, and 1% to 5% develop liver cancer (NIOSH. 1999).

 

Risk of Infection after a Needlestick Injury

After a needlestick exposure to an infected patient, a healthcare worker's risk of infection depends on the pathogen involved, the immune status of the worker, the severity of the needlestick injury, and the availability and use of appropriate post-exposure prophylaxis.

HIV

The Centers for Disease Control and Prevention's (CDC) published guidelines contend that the risk of healthcare personnel obtaining HIV infection from a percutaneous stick is .3% (DesRoches, 2003). One study of healthcare workers who had percutaneous exposures to HIV found that the risk of HIV transmission was increased when the worker was exposed to a larger quantity of blood from the patient, as indicated by (1) a visibly bloody device, (2) a procedure that involved placing a needle in a patient's vein or artery, or (3) a deep injury (NIOSH. 1999).

Post-exposure prophylaxis for HIV is recommended for healthcare workers occupationally exposed to HIV under certain circumstances. Early intervention with post-exposure prophylaxis (PEP) medication for 4 weeks post-exposure may prevent HIV infection by blocking spread of the virus to target cells or into the lymph system. Evidence weighs heavily on introducing PEP within 24 to 48 hours after an exposure to a patient who is an HIV positive source, a patient with HIV risk factors, or an exposure where the source patient is unknown but contact with patients who are HIV positive is high (DesRoches, 2003). Limited data suggest that such prophylaxis may considerably reduce the chance of becoming infected with HIV. However, the drugs used for HIV post-exposure prophylaxis have many adverse side effects. Currently no vaccine exists to prevent HIV infection, and no treatment exists to cure it (NIOSH. 1999).

HBV

The rate of HBV transmission to susceptible healthcare workers ranges from 6% to 30% after a single needlestick exposure to an HBV-infected patient (NIOSH. 1999). However, such exposures are a risk only for healthcare workers who are not immune to HBV. Healthcare workers who have antibodies to HBV either from pre-exposure vaccination or prior infection are not at risk. In addition, if a susceptible worker is exposed to HBV, post-exposure prophylaxis with hepatitis B immune globulin and initiation of hepatitis B vaccine is more than 90% effective in preventing HBV infection.

HCV

Recent research had identified significantly lower transmission rates of hepatitis C virus (HCV) in healthcare workers injured by HCV-contaminated needles. Studies of healthcare workers exposed to HCV through a needlestick or other percutaneous injury have found that the incidence of anti-HCV seroconversion (indicating infection) 0.5%. The Centers for Disease Control and Prevention (CDC) recommend testing for HCV antibodies and alanine aminotransferase levels initially and at 4 to 6 months after exposure, or-for earlier diagnosis-for HCV RNA at 4 to 6 weeks (Perry, Jagger & Parker, 2003). Currently no vaccine exists to prevent HCV infection, and neither immunoglobulin nor antiviral therapy is recommended as post-exposure prophylaxis (NIOSH. 1999). However, recommendations for treatment of early infections are rapidly evolving. Healthcare workers with known exposure should be monitored for seroconversion and referred for medical follow-up if seroconversion occurs.

Although exposure to HBV poses a high risk for infection, administration of pre-exposure vaccination or post-exposure prophylaxis to workers can dramatically reduce this risk. Such is not the case with HCV and HIV. Preventing the needlestick injury is the best approach to preventing these diseases in healthcare workers, and it is an important part of any bloodborne pathogen prevention program in the workplace.

 

How Needlestick Injuries Occur

Organizational factors appear important in healthcare workers' risk of injury. Working in hospitals using professional nurse practice models is associated with a several-fold reduction in the risk of injury (odds ratio, 0.18 to 0.37) among nurses. Further, nurse staffing ratios and the hospital safety climate have been shown to relate to the risk of percutaneous injury. Even when "safer" sharps devices are made available and used, they are often not adequately activated (Boebbeling, 2003)

Distraction, anger, and rushing were associated with the largest increase in risk of sharps-related injuries in one study. A trend toward increased risk of injury was seen when workers were fatigued, working on understaffed teams, dealing with an uncooperative patients, and among surgeons working in a noisy operating room (Anonymous, 2003).

Devices Associated with Needlestick Injuries

Healthcare workers use many types of needles and other sharp devices to provide patient care. However, data from hospitals participating in the CDC National Surveillance System for Hospital Healthcare Workers (NaSH) and from hospitals included in the EPINet research database show that only a few needles and other sharp devices are associated with the majority of injuries (NIOSH. 1999). Of nearly 5,000 percutaneous injuries reported by hospitals participating in NaSH between June 1995 and July 1999, 62% were associated with hollow-bore needles—primarily hypodermic needles attached to disposable syringes (29%) and winged-steel (butterfly-type) needles (13%). Figure 1 shows the extent to which these and other sharp devices contributed to the burden of percutaneous injuries in NaSH hospitals. Data from hospitals participating in EPINet show a similar distribution of injuries by device type (NIOSH. 1999).

Activities Associated with Needlestick Injuries

Whenever a needle or other sharp device is exposed, injuries can occur. Data from NaSH show that approximately 38% of percutaneous injuries occur during use and 42% occur after use and before disposal. Causes of percutaneous injuries with hollow-bore needles are shown in Figure 2.

The circumstances leading to a needlestick injury depend partly on the type and design of the device used. For example, needle devices that must be taken apart or manipulated after use (e.g., prefilled cartridge syringes and phlebotomy needle/vacuum tube assemblies) are an obvious hazard and have been associated with increased injury rates (NIOSH. 1999). In addition, needles attached to a length of flexible tubing (e.g., winged-steel needles and needles attached to IV tubing) are sometimes difficult to place in sharps containers and thus present another injury hazard. Injuries involving needles attached to IV tubing may occur when a healthcare worker inserts or withdraws a needle from an IV port or tries to temporarily remove the needlestick hazard by inserting the needle into a drip chamber, IV port or bag, or even bedding.

In addition to risks related to device characteristics, needlestick injuries have been related to certain work practices such as

  recapping,
   
  transferring a body fluid between containers, and
   
  failing to properly dispose of used needles in puncture-resistant sharps containers.

Past studies of needlestick injuries have shown that 10% to 25% occurred when recapping a used needle (NIOSH. 1999). Although recapping by hand has been discouraged for some time and is prohibited under the OSHA bloodborne pathogens standard [29 CFR 1910.1030] unless no alternative exists, 5% of needlestick injuries in NaSH hospitals are still related to this practice (Figure 2). Injury may occur when a healthcare worker attempts to transfer blood or other body fluids from a syringe to a specimen container (such as a vacuum tube) and misses the target. Also, if used needles or other sharps are left in the work area or are discarded in a sharps container that is not puncture resistant, a needlestick injury may result.

 


Figure 1. Hollow-bore needles and other devices associated with percutaneous injuries in NaSH hospitals, by % total percutaneous injuries (n=4,951), June 1995—July 1999 (NIOSH. 1999).

 

 


Figure 2. Causes of percutaneous injuries with hollow-bore needles in NaSH hospitals, by % total percutaneous injuries (n=3,057), June 1995—July 1999 (NIOSH. 1999).
 

 

OSHA and FDA

OSHA

The current Federal standard for addressing needlestick injuries among healthcare workers is the OSHA bloodborne pathogens standard [29 CFR 1910.1030; 56 Federal Register 64004 (1991)], which has been in effect since 1992. The standard applies to all occupational exposures to blood or other potentially infectious materials. Notable elements of this standard require the following (NIOSH. 1999):

  A written exposure control plan designed to eliminate or minimize worker exposure to bloodborne pathogens
   
Compliance with universal precautions (an infection control principle that treats all human blood and other potentially infectious materials as infectious)
   
Engineering controls and work practices to eliminate or minimize worker exposure
   
Personal protective equipment (if engineering controls and work practices do not eliminate occupational exposures)
   
Prohibition of bending, recapping, or removing contaminated needles and other sharps unless such an act is required by a specific procedure or has no feasible alternative
   
Prohibition of shearing or breaking contaminated needles (OSHA defines contaminated as the presence or the reasonably anticipated presence of blood or other potentially infectious materials on an item or surface)
   
Free hepatitis B vaccinations offered to workers with occupational exposure to bloodborne pathogens
   
Worker training in appropriate engineering controls and work practices
   
Post-exposure evaluation and followup, including post-exposure prophylaxis when appropriate

OSHA also intends to act to reduce the number of injuries that healthcare workers receive from needles and other sharp medical objects. First, the agency has revised the compliance directive (guidance to be used in the field) accompanying its 1992 bloodborne pathogens standard [29 CFR 1910.1030] to reflect newer and safer technologies now available and to increase the employer's responsibility to evaluate and use effective, safer technologies (NIOSH. 1999). Second, the agency has proposed a requirement in the revised recordkeeping rule that all injuries resulting from contaminated needles and sharps be recorded on OSHA logs used by employers to record injuries and illnesses. Finally, OSHA will take steps to amend its bloodborne pathogens standard by placing needlestick and sharps injuries on its regulatory agenda.

FDA

Under the regulations of the Food and Drug Administration (FDA) application clearance process, the manufacturers of medical devices (including needles used in patient care) must meet requirements for appropriate registration and for listing, labeling, and good manufacturing practices for design and production. The process for receiving clearance or approval to market a device requires device manufacturers to (1) demonstrate that a new device is substantially equivalent to a legally marketed device or (2) document the safety and effectiveness of the new device for patient care through a more involved premarket approval process. FDA has also released two advisories pertaining to sharps and the risk of bloodborne pathogen transmission in the healthcare setting (NIOSH. 1999).

 

Case Reports

The following case reports briefly describe the experiences of five healthcare workers who developed serious infections after occupational exposures to bloodborne pathogens (NIOSH. 1999). Their cases illustrate a number of the preventable hazardous conditions and practices that can lead to needlestick injuries.

Case 1

A hospitalized patient with AIDS became agitated and tried to remove the intravenous (IV) catheters in his arm. Several hospital staff members struggled to restrain the patient. During the struggle, an IV infusion line was pulled, exposing the connector needle that was inserted into the access port of the IV catheter. A nurse at the scene recovered the connector needle at the end of the IV line and was attempting to reinsert it when the patient kicked her arm, pushing the needle into the hand of a second nurse. The nurse who sustained the needlestick injury tested negative for HIV that day, but she tested HIV positive several months later.

Case 2

A physician was drawing blood from a patient in an examination room of an HIV clinic. Because the room had no sharps disposal container, she recapped the needle using the one-handed technique. While the physician was sorting waste materials from lab materials, the cap fell off the phlebotomy needle, which subsequently penetrated her right index finger. The physician's baseline HIV test was negative. She began post-exposure prophylaxis with zidovudine but discontinued it after 10 days because of adverse side effects. Approximately 2 weeks after the needlestick, the physician developed flu-like symptoms consistent with HIV infection. She was found to be seropositive for HIV when tested 3 months after the needlestick exposure.

Case 3

After performing phlebotomy on a patient with AIDS, a healthcare worker sustained a deep needlestick injury with the used phlebotomy needle. Blood from the collection tube also spilled into the space between the wrist and cuff of the healthcare worker's gloves, contaminating her chapped hands. The healthcare worker removed the gloves and washed her hands immediately. She had a negative baseline HIV test and refused zidovudine prophylaxis. Because her patient was not known to have HCV infection and did not have clinical evidence of liver disease, the healthcare worker did not receive baseline testing for exposure to HCV. Eight months after the incident, the healthcare worker was hospitalized with acute hepatitis. She was found to be seropositive for HIV nine months after the incident. Sixteen months after the incident, she tested positive for anti-HCV antibodies and was diagnosed with chronic HCV infection. Her clinical condition continued to deteriorate, and she died 28 months after the needlestick injury.

Case 4

During bronchoscopy to determine the cause of shortness of breath in a patient infected with HBV, a healthcare worker sustained a percutaneous injury with a 25-gauge needle while extracting tissue from biopsy forceps. The worker did not receive post-exposure prophylaxis with hepatitis B immune globulin or hepatitis B vaccine. Approximately 15 weeks after the needlestick injury, the worker noted fatigue, malaise, and jaundice. Later, he was found to have abnormal liver enzymes and a positive test for hepatitis B surface antigen, consistent with acute hepatitis B infection. The patient who underwent bronchoscopy was diagnosed with Pneumocystis carinii pneumonia and died 8 months later after he was diagnosed with disseminated Kaposi's sarcoma and overwhelming opportunistic infection. The injured worker had an uncomplicated medical course, and his liver enzymes and his health eventually returned to normal. He later tested negative for hepatitis B surface antigen and positive for hepatitis B surface antibody, indicating recovery from his HBV infection. On followup 15 months after the needlestick injury, the worker also tested HIV negative; serum from the deceased patient was not available for antibody testing.

Case 5

In 1972, a nurse sustained a needlestick injury to her finger while removing a hypodermic needle from a patient's arm. At the time of the injury, the source patient had apparent acute non-A, non-B hepatitis. The nurse developed hepatitis 6 weeks after the needlestick injury. Her liver enzymes remained elevated for nearly a year. Later examination of serum samples from the nurse and the source patient showed that both persons were infected with HCV. The initial serum sample from the nurse in 1972 was negative for anti-HCV antibody, but the sample obtained 6 weeks after the needlestick injury was seropositive. Although the nurse was clinically well at the time of the report, she remained seropositive for HCV.

 

Improved Engineering Controls

Comprehensive Programs to Prevent Needlestick Injuries

Safety and health issues can best be addressed in the setting of a comprehensive prevention program that considers all aspects of the work environment and that has employee involvement as well as management commitment. Implementing the use of improved engineering controls is one component of such a comprehensive program. Since many devices with needlestick prevention features are new, this section primarily addresses their use, including desirable characteristics, examples, and data supporting their effectiveness. However, other prevention strategy factors that must be addressed include modification of hazardous work practices, administrative changes to address needle hazards in the environment (e.g., prompt removal of filled sharps disposal boxes), safety education and awareness, feedback on safety improvements, and action taken on continuing problems. The critical role of appropriate training has been emphasized by several recent reports of increased patient bloodstream infections associated with improper care of needleless IV systems, primarily in the home healthcare setting (NIOSH. 1999). These data emphasize the need for patient safety surveillance and thorough training as well as occupational injury surveillance when implementing the use of a new medical device.

Case Study of a Successful Comprehensive Prevention Program (NIOSH. 1999)

The value of a comprehensive approach is illustrated by its success in a recent report. Between 1993 and 1996, the phlebotomy service at a major institution decreased the needlestick injury rate among its 200 full-time phlebotomists from 1.5 to 0.2 per 10,000 venipunctures performed. In comparison, a national survey from 1990 to 1992 found a median needlestick injury rate of about 0.94 per 10,000 venipunctures. A retrospective review of the events contributing to the success of the phlebotomy service included changes in worker education and work practices, the implementation of devices with safety features, and encouragement of injury reporting. These interventions as well as the implementation of CDC published guidelines and the OSHA bloodborne pathogens standard were associated with the observed steady decline in the injury rate. The authors noted that an important factor contributing to this success was a thorough understanding of the injuries that occurred among their staff.

Desirable Characteristics of Devices with Safety Features

Improved engineering controls are often among the most effective approaches to reducing occupational hazards and therefore are an important element of a needlestick prevention program. Such controls include eliminating the unnecessary use of needles and implementing devices with safety features. A number of sources have identified the desirable characteristics of safety devices]. These characteristics include the following (NIOSH. 1999):

  The device is needleless.
   
  The safety feature is an integral part of the device.
   
  The device preferably works passively (i.e., it requires no activation by the user). If user activation is necessary, the safety feature can be engaged with a single-handed technique and allows the worker's hands to remain behind the exposed sharp.
   
  The user can easily tell whether the safety feature is activated.
   
  The safety feature cannot be deactivated and remains protective through disposal.
   
  The device performs reliably.
   
  The device is easy to use and practical.
   
  The device is safe and effective for patient care.

Although each of these characteristics is desirable, some are not feasible, applicable or available for certain healthcare situations. For example, needles will always be necessary where alternatives for skin penetration are not available. Also, a safety feature that requires activation by the user might be preferable to one that is passive in some cases. Each device must be considered on its own merit and ultimately on its ability to reduce workplace injuries. The desirable characteristics listed here should thus serve only as a guideline for device design and selection.

Examples of Safety Device Designs

Figure 3 shows examples of syringes with safety features. These and other examples of safety device designs are listed as follows (NIOSH. 1999):

  Needleless connectors for IV delivery systems (e.g., blunt cannula for use with prepierced ports and valved connectors that accept tapered or luer ends of IV tubing)
   
  Protected needle IV connectors (e.g., the IV connector needle is permanently recessed in a rigid plastic housing that fits over IV ports)
   
  Needles that retract into a syringe or vacuum tube holder
   
  Hinged or sliding shields attached to phlebotomy needles, winged-steel needles, and blood gas needles
   
  Protective encasements to receive an IV stylet as it is withdrawn from the catheter
   
  Sliding needle shields attached to disposable syringes and vacuum tube holders
   
  Self-blunting phlebotomy and winged-steel needles (a blunt cannula seated inside the phlebotomy needle is advanced beyond the needle tip before the needle is withdrawn from the vein—see Figure 3)
   
  Retractable finger/heel-stick lancets

 

 


Figure 3. Three examples of syringes with safety features. (These drawings are presented for educational purposes and do not imply endorsement of a particular product by NIOSH) (NIOSH. 1999).
 

Evidence of Effectiveness

Accumulating evidence indicates that devices with safety features reduce needlestick injuries (NIOSH. 1999):

  Needleless or protected-needle IV systems decreased needlestick injuries related to IV connectors by 62% to 88%.
   
  Phlebotomy injuries were reduced by 76% with a self-blunting needle, 66% with a hinged needle shield, and 23% with a sliding-shield, winged-steel (butterfly-type) needle.
   
  Phlebotomy injuries were reduced by 82% with a needle shield, but a recapping device had minimal impact.
   
  Safer IV catheters that encase the needle after use reduced needlestick injuries related to IV insertion by 83% in three hospitals.

Other studies also document substantial reductions in needlestick injuries with the proper use of needleless systems or newer safety needle devices used in a comprehensive program to prevent needlestick injuries (NIOSH. 1999). Although the focus in this section is on needle devices with safety features, sharps disposal containers are also important engineering controls to consider in a comprehensive needlestick injury prevention program. NIOSH recently reviewed the proper location, use, and benefits of sharps disposal containers.

As illustrated by the examples listed here, many devices with safety features decrease the frequency of needlestick injuries, but for many reasons they do not completely eliminate the risk. In some cases, the safety feature cannot be activated until after the needle is removed from the patient. Or the needle may be inadvertently dislodged during a procedure, thereby exposing the unprotected sharp. Some healthcare workers fail to activate the safety feature, or the safety feature may fail. With some devices, users can bypass safety features. For example, even with some needleless IV delivery systems, a needle can be used to connect parts of the system. Understanding the factors that influence the safety of a device and promoting practices that will maximize prevention effectiveness are therefore important components in prevention planning.

 

Recommendations

Selecting and Evaluating Needle Devices with Safety Features

An increasing number and variety of needle devices with safety features are now available, but many of these devices have had only limited use in the workplace. Thus healthcare organizations and workers may find it difficult to select appropriate devices. Although these devices are designed to enhance the safety of healthcare workers, they should be evaluated to ensure that

  the safety feature works effectively and reliably,
   
  the device is acceptable to the healthcare worker, and
   
  the device does not adversely affect patient care.

As employers implement the use of needle devices with safety features, they can use several guidelines to select and evaluate these products. These guidelines are derived partly from publications and other resources offering plans, evaluation forms, and related information in this new area (NIOSH. 1999). While healthcare settings are implementing the use of needle devices with safety features, they should seek help from the appropriate professional organizations, trade groups, and manufacturers in obtaining information about devices and procedures suitable for specific settings (e.g. dental offices).

The major elements of a process for selecting and evaluating needle devices with safety features are listed here briefly (NIOSH. 1999):

1. Form a multidisciplinary team that includes workers to (1) develop, implement, and evaluate a plan to reduce needlestick injuries in the institution and (2) evaluate needle devices with safety features.
   
2. Identify priorities based on assessments of how needlestick injuries are occurring, patterns of device use in the institution, and local and national data on injury and disease transmission trends. Give the highest priority to needle devices with safety features that will have the greatest impact on preventing occupational infection (e.g., hollow-bore needles used in veins and arteries).
   
3. When selecting a safer device, identify its intended scope of use in the healthcare facility and any special technique or design factors that will influence its safety, efficiency, and user acceptability. Seek published, Internet, or other sources of data on the safety and overall performance of the device.
   
4. Conduct a product evaluation, making sure that the participants represent the scope of eventual product users. The following steps will contribute to a successful product evaluation:
   

   

Train healthcare workers in the correct use of the new device.
   
    Establish clear criteria and measures to evaluate the device with regard to both healthcare worker safety and patient care. (Safety feature evaluation forms are available from the references cited earlier.)
   
    Conduct onsite followup to obtain informal feedback, identify problems, and provide additional guidance.
   
5. Monitor the use of a new device after it is implemented to determine the need for additional training, solicit informal feedback on healthcare worker experience with the device (e.g., using a suggestion box), and identify possible adverse effects of the device on patient care.

Ongoing review of current devices and options will be necessary. As with any evolving technology, the process will be dynamic, and with experience, improved devices with safety features will emerge.

Recommendations for Employers

To protect healthcare workers from needlestick injuries, employers must provide a safe working environment that includes safer needle devices and effective safety programs. Many types of needle devices are associated with needlestick injuries, and these injuries can occur in many ways. Thus a combination of prevention strategies must be considered. Employers should take the following steps to implement a program for reducing needlestick injuries and to involve workers in this effort (NIOSH. 1999).

1. Employers of healthcare workers should implement the use of improved engineering controls to reduce needlestick injuries:
   

   

Eliminate the use of needle devices where safe and effective alternatives are available. The most obvious example of unnecessary needle use is the use of exposed needles to access or connect parts of an IV delivery system. For nearly a decade, needleless IV delivery systems and protected needles have been available to remove or isolate this hazard. Examine information about your own institution to identify other unnecessary needle use.

   
    Implement the use of needle devices with safety features and evaluate their use to determine which are most effective and acceptable. Many devices are now available with safety features that isolate an exposed needle after use. An evaluation approach and references are provided in this document.
2. Needlestick injury reduction can best be accomplished when the use of improved engineering controls is incorporated into a comprehensive program involving workers:
   

   

Analyze needlestick and other sharps-related injuries in your workplace to identify hazards and injury trends. Data from injury reporting should be compiled and assessed to identify (1) where, how, with what devices, and when injuries are occurring and (2) the groups of healthcare workers being injured.

   
    Set priorities and prevention strategies by examining local and national information about risk factors for needlestick injuries and successful intervention efforts. Procedures and devices that have contributed to disease transmission (e.g., devices used to access a vein or artery) should receive the highest priority for intervention. Look to local and national resources for information about the types of devices and work practices that have been successful in reducing injuries.
   
    Ensure that healthcare workers are properly trained in the safe use and disposal of needles. Healthcare workers and students in the health professions should be trained to use needle devices properly and to maximize their personal protection throughout the handling of these devices. As safer devices are introduced, worker training is essential to ensure proper use.
   
    Modify work practices that pose a needlestick injury hazard to make them safer. Hazards that can be eliminated by modifying work practices include injuries due to recapping, failing to dispose of a needle device properly, passing or transferring such a device, and transferring blood or body fluids from a device into a specimen container. Also, specimen collection can be coordinated to reduce the number of times needles are used on a patient, thereby reducing both worker risk and patient discomfort. In some cases, the use of devices with safety features will reduce or eliminate these risks. In all cases, involving healthcare workers will help identify and resolve safety issues. Employers should thus review current procedures for reporting and addressing hazards related to needles and other sharps.
   
    Promote safety awareness in the work environment. Many needlestick injuries result from unexpected circumstances such as sudden movement by a patient or collision with a coworker or needle device. Healthcare workers should be trained to be constantly alert to the injury potential when an exposed needle or other sharp device is being used. A number of job-related factors influence the adoption of safety behaviors by healthcare workers. These workers often place patient needs before their personal safety. They are less likely to perform a safety measure they perceive to interfere with patient care or to require added steps. Therefore, employers must address both the hazards that contribute to needlestick injuries and the institutional barriers and attitudes that affect safe work practices.
   
    Establish procedures for and encourage the reporting and timely followup of all needlestick and other sharps-related injuries. Reporting of needlestick injuries is essential to (1) ensure that all healthcare workers receive appropriate post-exposure medical management and (2) provide a record for assessing needlestick hazards in the work environment.
   
    Evaluate the effectiveness of prevention efforts and provide feedback on performance. Employers need to ensure that healthcare workers are adopting the recommended prevention strategies and that the changes they make have the desired effect. Thus, they should provide a forum to assess worker perceptions, evaluate compliance, and identify problems.

Recommendations for Workers

To protect them and their coworkers, healthcare workers should be aware of the hazards posed by needlestick injuries and should use safety devices and improved work practices as follows (NIOSH. 1999):

1. Avoid the use of needles where safe and effective alternatives are available.
   
2. Help your employer select and evaluate devices with safety features.
   
3. Use devices with safety features provided by your employer.
   
4. Avoid recapping needles.
   
5. Plan safe handling and disposal before beginning any procedure using needles.
   
6. Dispose of used needle devices promptly in appropriate sharps disposal containers.
   
7. Report all needlestick and other sharps-related injuries promptly to ensure that you receive appropriate followup care.
   
8. Tell your employer about hazards from needles that you observe in your work environment.
   
9. Participate in bloodborne pathogen training and follow recommended infection prevention practices, including hepatitis B vaccination.

 

Additional Information

For additional information about needlestick injuries, call 1-800-35-NIOSH (1-800-356-4674); or visit the NIOSH Web site at www.cdc.gov/niosh.

The following Web sites provide additional information about needlestick injuries and safer needle devices:

  University of Virginia's International Healthcare Workers Safety Center and its EPINet needlestick injury data collection system: www.med.virginia.edu/~epinet (or call 804-982-0702)
   
  San Francisco General Hospital's Trauma Foundation, Training for Development of Innovative Control Technology (TDICT) Project: www.tdict.org (or call 415-821-8209)
   
  OSHA Web page: www.osha.gov; for needlestick information, www.osha-slc.gov/SLTC/ needlestick/index.html (or call the OSHA Publications Office at 202-693-1888)
   
  CDC Web page: www.cdc.gov; for hepatitis information, www.cdc.gov/ ncidod/diseases/hepatitis/ index.htm; for hospital infections, www.cdc.gov/ncidod/hip/ default.htm; and for HIV information, www.cdc.gov/nchstp/hiv_aids/dhap.htm
   
  FDA medical device safety alerts: www.fda.gov/cdrh/safety.html

 

Reference

Anonymous, (2003). Distraction, anger, rushing associated with sharps injuries. OR Manager 19(8) p 32. Retrieved October 29, 2003 from this URL

Boebbeling, B. (2003). Lessons regarding percutaneous injuries among healthcare providers. Infection Control and Hospital Epidemiology. 24(2) p 82-86. Retrieved October 29, 2003 from this URL

DesRoches, P. & Moore, P. (2003). HIV post-exposure prophylaxis (PEP) - Effect on management of bloodborne pathogen exposures in the healthcare environment. AAOHN Journal. 51(9) p 370. Retrieved October 29, 2003 from this URL

NIOSH. (1999). Alert: Preventing needlestick injuries in healthcare settings. DSSH NIOSH publication 2000-108. Retrieved October 29, 2003, from this URL

Perry, J., Jagger, J. & Parker, G. (2003). Statistically, your risk of HCV Infection has dropped. Nursing. 33(6). this URL

Perry, J., Jagger, J. & Parker, G. (2003). Nurses and needlesticks, then and now. Nursing. 33(4) p 22. Retrieved October 29, 2003, from this URL